CCI Testing of Vials at Ultra-Cold Storage Temperatures
Many pharmaceutical products today depend on ultra-cold storage to preserve their effectiveness throughout their shelf life. Biologics, vaccines, and cell and gene therapies often require storage below -80°C, creating unique challenges for pharmaceutical packaging. Low temperatures can alter the physical properties of vial components, potentially affecting container closure integrity. Small defects that are not visible at room temperature may become more significant under cryogenic conditions, increasing the possibility of contamination or product degradation.
Helium leak detection is one of the most sensitive deterministic technologies available for evaluating vial integrity under these demanding conditions. By introducing helium as a tracer gas and measuring its escape with mass spectrometry, manufacturers can detect extremely small leaks with exceptional accuracy. This quantitative approach provides reliable data that supports packaging validation and quality assurance.
Testing vials at actual storage temperatures allows manufacturers to better understand package performance during development, production, transportation, and long-term storage. The results help optimize packaging materials, validate sealing processes, and support stability programs while reducing the likelihood of product failures. Ultra-cold CCI testing also contributes to regulatory compliance by providing scientifically reliable leak detection data. As demand for temperature-sensitive pharmaceuticals continues to grow, helium leak detection plays a key role in ensuring package integrity and protecting valuable drug products throughout the cold chain.












